Wise Young - Net Worth and Insider Trading

Wise Young Net Worth

The estimated net worth of Wise Young is at least $2 dollars as of 2024-11-13. Wise Young is the Director of Acorda Therapeutics Inc and owns about 139 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $2. Details can be seen in Wise Young's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wise Young has not made any transactions after 2006-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Wise Young

To

Wise Young Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wise Young owns 1 companies in total, including Acorda Therapeutics Inc (ACORQ) .

Click here to see the complete history of Wise Young’s form 4 insider trades.

Insider Ownership Summary of Wise Young

Ticker Comapny Transaction Date Type of Owner
ACORQ Acorda Therapeutics Inc 2006-02-09 director

Wise Young Latest Holdings Summary

Wise Young currently owns a total of 1 stock. Wise Young owns 139 shares of Acorda Therapeutics Inc (ACORQ) as of February 9, 2006, with a value of $2.

Latest Holdings of Wise Young

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACORQ Acorda Therapeutics Inc 2006-02-09 139 0.01 2

Holding Weightings of Wise Young


Wise Young Form 4 Trading Tracker

According to the SEC Form 4 filings, Wise Young has made a total of 0 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years. The most-recent trade in Acorda Therapeutics Inc is the sale of 0 shares on February 9, 2006, which brought Wise Young around $0.

Insider Trading History of Wise Young

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wise Young Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wise Young Ownership Network

Ownership Network List of Wise Young

No Data

Ownership Network Relation of Wise Young

Insider Network Chart

Wise Young Owned Company Details

What does Acorda Therapeutics Inc do?

Who are the key executives at Acorda Therapeutics Inc?

Wise Young is the director of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .

Acorda Therapeutics Inc (ACORQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acorda Therapeutics Inc Insider Transactions

No Available Data

Wise Young Mailing Address

Above is the net worth, insider trading, and ownership report for Wise Young. You might contact Wise Young via mailing address: C/o Acorda Therapeutics, Inc., 15 Skyline Drive, Hawthorne Ny 10532.